Better drug monitoring after kidney transplant
This study tests a new way to monitor levels of your anti-rejection medicines using text messages. It aims to make sure you get the right dose and stay healthy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had a solid organ transplant, like a kidney.
- You are at least 1 year old.
- You are taking tacrolimus or mycophenolate, which are anti-rejection medicines.
- You or your caregiver can receive and send text messages on a mobile device.
- You must be able to read and speak English.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study looks at whether blood test “biomarkers” can guide safely changing anti-rejection medicines after an ABO-compatible kidney transplant. It may help some people reduce certain medicines while keeping the new kidney protected from rejection.
This study tests a new way to monitor harmful antibodies after a kidney transplant. It may help prevent transplant rejection over time.
This trial is testing a new blood test (called TreaT-Assay) to help diagnose acute rejection after a kidney transplant. The goal is to catch rejection earlier and more accurately, so you can get the right treatment faster.
This study tests technology (like text reminders and an electronic pill box) to help adolescents and young adults who received a kidney or liver transplant take their medicines every day. It may help protect the transplant by improving medication adherence.
This trial uses a personalized approach (including tacrolimus medication planning and monitoring) to better understand how a kidney transplant is doing. It may help your transplant team tailor care to your kidney function over time.
This trial tests a program to help kidney transplant patients stick to their immunosuppressive medication schedule. It uses phone check-ins to support you after your transplant.
Hear when a new Kidney Transplant trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.